Skip to main content
    T

    Telomir Pharmaceuticals, Inc. Common Stock (TELO)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $0.48
    -0.01 (-1.96%)

    Market Cap: $36.15M

    Last updated: Nov 17, 2026 at 11:04 AM ET

    Telomir Pharmaceuticals, Inc. Common Stock (TELO) Stock Forecast

    Updated Nov 17, 2026. Estimates and ratings come from consensus analyst data.

    Analysts expect Telomir Pharmaceuticals, Inc. Common Stock (TELO) to earn -$0.11 per share in the fiscal year ending Dec 31, 2026. For the fiscal year ending Dec 31, 2027, the EPS consensus is -$0.17.

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Annual Estimates

    Fiscal year ending Dec 31, 2026
    -$0.11
    EPS consensus
    Fiscal year ending Dec 31, 2027
    -$0.17
    EPS consensus
    Next report
    Mar 15, 2027
    Estimated

    EPS range

    Fiscal year endingEPS consensusEPS rangeEPS analysts
    Dec 31, 2026-$0.11-$0.11 to -$0.111
    Dec 31, 2027-$0.17-$0.17 to -$0.171

    Quarterly Estimates

    Quarter endingEPS consensusEPS rangeEPS analysts
    Mar 31, 2027-$0.04-$0.04 to -$0.041

    Estimate Revisions

    No EPS estimate for the 3 periods below was revised in the last 30 days.

    PeriodUp 30 daysDown 30 days
    Fiscal year ending Dec 31, 202600
    Fiscal year ending Dec 31, 202700
    Quarter ending Mar 31, 202700

    Frequently Asked Questions About TELO

    What is the TELO stock forecast?

    Consensus analyst estimates put Telomir Pharmaceuticals, Inc. Common Stock's EPS at -$0.11 for the fiscal year ending Dec 31, 2026.

    What EPS do analysts expect from TELO next year?

    For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is -$0.11, with estimates from -$0.11 to -$0.11 from 1 analyst. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is -$0.17, with estimates from -$0.17 to -$0.17 from 1 analyst.

    How many analysts cover TELO?

    1 analyst estimates EPS for Telomir Pharmaceuticals, Inc. Common Stock for the fiscal year ending Dec 31, 2026.